Author(s)

Junjian Liu, Tian Wei, Zhiping Xiang, Yinlu Ding

Department of Gastrointestinal Surgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China.

Gastric cancer is one of the most common malignant tumours worldwide, with a high degree of malignancy and a poor prognosis. While early gastric cancer can be cured by surgical treatment, locally advanced gastric cancer requires neoadjuvant therapy to shrink the tumour, suppress potential metastases, achieve down-staging, and provide patients with the opportunity for radical surgery to prolong their survival. This article reviews the current status and progress of neoadjuvant chemotherapy for locally advanced gastric cancer.

Locally Advanced Gastric Cancer, Adjuvant Chemotherapy, Neoadjuvant Chemotherapy

Liu, J. , Wei, T. , Xiang, Z. and Ding, Y. (2023) Current Status and Research Progress of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer. Journal of Biosciences and Medicines, 11, 156-170. doi: 10.4236/jbm.2023.113016.